ChinaBulls

Maijing Gene迈景基因

Enterprise Software/SaaS

MyGenostics is a developer of cancer genetic testing technologies centered on medical bioinformatics and next-generation sequencing. It develops test kits for hereditary cancer risk assessment, early screening, companion diagnostics, and prognosis monitoring, covering cancers including breast…

Source: ChinaBulls — chinabulls.com

Last updated 2022-12-01

Funding Rounds

  • Series C
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

Maijing Gene Fundraising Info

Company fundraising information requires an account.

Maijing Gene Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP